Ceribell Execs to Discuss Strategy at Bank of America Health Care Conference
Event summary
- Ceribell CEO Jane Chao and CFO Scott Blumberg to participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference on May 13, 2026.
- Event scheduled for 3:40 p.m. PST / 6:40 p.m. EST.
- Live and archived webcast available on Ceribell's Investor Relations page.
- Ceribell focuses on point-of-care EEG technology for acute neurological conditions.
The big picture
Ceribell's participation in the Bank of America Securities conference underscores its push for investor visibility amid growing competition in neurodiagnostic tools. The company's focus on AI-driven EEG solutions aligns with broader trends in digital health, where rapid, portable diagnostics are gaining traction in acute care settings. Ceribell's ability to scale its technology beyond current FDA-cleared applications will be critical to its long-term valuation.
What we're watching
- Strategic Messaging
- How Ceribell positions its AI-powered EEG technology in a competitive neurodiagnostic market.
- Market Expansion
- Whether Ceribell can accelerate adoption beyond ICU and ER settings.
- Financial Performance
- The pace at which Ceribell converts clinical adoption into revenue growth.
Related topics